Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05800119 · ClinicalTrials.gov registry record · NA
An Intervention to Correct Dualistic Reasoning About the Effectiveness of Psychotherapy for Biologically Caused Mental Disorders
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 1,243
- Enrollment target
NCT05800119: Completed NA study, sponsored by Yale University.
NCT05800119 is a NA study that has completed, run by Yale University. The registered enrollment target is 1,243 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05800119, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,243 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test in three samples, including sample 1: lay people without reported depression symptoms, sample 2: lay people with reported depression symptoms and sample 3: mental health clinicians. The main questions it aims to answer are: 1) do each of these populations show a bias against psychotherapy wherein they judge psychotherapy to be less effective, relative to baseline ratings, when a mental illness (i.e., depression) is attributed to biological factors, 2) whether an intervention emphasizing the neurobiological effects of psychotherapy can remove this bias against psychotherapy for biologically-caused mental disorders, and 3) whether this intervention is more effective compared to an active control intervention that emphasizes the effectiveness of psychotherapy, but not its neurobiological effects. Participants will * rate the effectiveness of psychotherapy for depression before and after learning about the biological causes of depression * be assigned to one of three conditions: 1) an intervention condition where participants will receive a brief reading passage (approximately 126 words in length) providing psychoeducation about how psychotherapy changes the brain of an individual with depression, or 2) an active control condition where participants will receive a reading passage (approximately 115 words) emphasizing the effectiveness of psychotherapy, or 3) a control condition where they will receive no additional materials * as a secondary outcome, participants will also rate the effectiveness of medication for depression, before and after learning about the biological causes of depression
Primary Outcome
This outcome is measured with two questions, both on a 1-7 rating scale. The questions measure participants' beliefs about the effectiveness of psychotherapy. These two questions were asked on an online survey where participants completed the questions at pretest (before participants learned about the biological causes of depression, and were assigned to one of the three conditions) and at post-test. The questions were as follows: 1) "how effective would psychotherapy treatment be at addressing
Interventions
- BEHAVIORAL Brain-level condition
- OTHER Mind-level condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,243 participants |
| Start Date | 2020-09-18 |
| Est. Completion | 2022-04-02 |
| Phase | NA |
What the finished NCT05800119 record still lists
NCT05800119 is an interventional study that assigns participants to a tested intervention. Its 1,243 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (11% lower).
The record links to 0 conditions, and to 2 interventions - of which Brain-level condition is the first listed.
NCT05800119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05800119 about?
NCT05800119 is a clinical study titled "An Intervention to Correct Dualistic Reasoning About the Effectiveness of Psychotherapy for Biologically Caused Mental Disorders". The goal of this clinical trial is to test in three samples, including sample 1: lay people without reported depression symptoms, sample 2: lay people with reported depression symptoms and sample 3: mental health clinicians. The main questions it aims to answer are: 1) do each of these populations s...
What is the current status of trial NCT05800119?
This trial is currently completed. It is a NA study. The enrollment target is 1,243 participants. The study started on 2020-09-18. Estimated completion is 2022-04-02.
What interventions are being tested in trial NCT05800119?
The interventions under investigation include: Brain-level condition (BEHAVIORAL), Mind-level condition (OTHER).
Who is sponsoring clinical trial NCT05800119?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05800119's enrollment target sits among peer trials
1,243 82nd of 2000 higher than 1,919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06368245 · 1,244 participants
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI